Customer Guest
please type the captcha code.
Register|Generate Password|Dos and Don'ts of Demat Account
For Login related queries e-mail: emkayassist@emkayglobal.com
"Attention Investors
1. Stock Brokers can accept securities as margin from clients only by way of pledge in the depository system w.e.f. September 1, 2020. 2. Update your mobile number & email Id with your stock broker/depository participant and receive OTP directly from depository on your email id and/or mobile number to create pledge. 3. Pay 20% upfront margin of the transaction value to trade in cash market segment. 4. Investors may please refer to the Exchange's Frequently Asked Questions (FAQs) issued vide circular reference NSE/INSP/45191 dated July 31, 2020 and NSE/INSP/45534 dated August 31, 2020 and other guidelines issued from time to time in this regard. 5. Check your Securities /MF/ Bonds in the consolidated account statement issued by NSDL/CDSL every month. 6.Investor Charter 7.Disclosure of Complaints 8.COMPLAINTS / SCORES 9. Verify Nomination in Account, click on link (:: Central Depository Services (India) Limited :: )
.......... Issued in the interest of Investors"
Regenerate OTP
Please contact to emkayassist@emkayglobal.com
Please select Mobile No and Email Id for OTP
Login | Register
Login | Register|Forgot password?
Ajanta Pharma Limited has informed the Exchange about Copy of Newspaper Publicationmore...
Ajanta Pharma Limited has informed the Exchange about Link of Recordingmore...
PFA Audio recoding of Earnings Callmore...
Ajanta Pharma Limited has informed the Exchange about General Updatesmore...
PFA Reg 30 Disclosure of SEBI LODRmore...
The company reported standalone net profit of Rs 197.28 crore for the quarter ended March 31 2026 as compared to Rs 193.43 crore in the same...more...
PFA Intimation w.r.t grant and cancellation of ESOPsmore...
PFA BM Outcomemore...
PFA Audited Financial Resultsmore...
Ajanta Pharma Limited has submitted to the Exchange the financial results for the period ended March 31 2026.more...
Ajanta Pharma on Wednesday said the US Food and Drug Administration has issued a Form 483 with five observations for its manufacturing facil...more...
Pls find enclosed Reg 30 disclosuremore...
Ajanta Pharma Limited has informed the Exchange about Schedule of meetmore...
Pls find enclosed herewith Investor Call Intimation.more...
Ajanta Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/05/2026 inter alia to consider and app...more...
As of March 2026 66.25% is owned by Indian Promoters and 33.75% by Public. Institutional holds 26.62% (Insurance Companies 2.70%) and Non-In...more...
YOGESH M. AGRAWAL has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantia...more...
Ajanta Pharma Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations 2018more...
BOARD MEETINGS Company Name : Abhinav Cap. Serv. Date : 14-05-2026